Comparative study demonstrates enhanced detection of autoantibodies in myositis patients, suggesting improved diagnostic accuracy.
LIPS provides quantitative discrimination, strong concordance with IP, and improved performance compared with line blot, particularly at low to intermediate titers. By reducing misclassification and complementing antibody-specific thresholds, LIPS has the potential to enhance clinical stratification in myositis patients.
No takes yet. Share an insight, caveat, or question.
Burbelo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: